Works matching AU Hasegawa, Kosei


Results: 133
    1
    2
    3

    Gut microbiome associated with PARP inhibitor efficacy in patients with ovarian cancer.

    Published in:
    Journal of Gynecologic Oncology, 2025, v. 36, n. 3, p. 1, doi. 10.3802/jgo.2025.36.e38
    By:
    • Okazawa-Sakai, Mika;
    • Sakai, Shunsuke A.;
    • Ichinosuke Hyodo;
    • Satoshi Horasawa;
    • Kentaro Sawada;
    • Takao Fujisawa;
    • Yasuko Yamamoto;
    • Shogen Boku;
    • Yoh Hayasaki;
    • Masanori Isobe;
    • Daisuke Shintani;
    • Kosei Hasegawa;
    • Tomomi Egawa-Takata;
    • Kimihiko Ito;
    • Kei Ihira;
    • Hidemichi Watari;
    • Kazuhiro Takehara;
    • Hiroshi Yagi;
    • Kiyoko Kato;
    • Tatsuyuki Chiyoda
    Publication type:
    Article
    4
    5
    6
    7
    8
    9

    Pharmacokinetic and Exposure–Response Modeling Support Body Surface Area‐Based Dosing of Farletuzumab Ecteribulin in Japanese Patients with Solid Tumors.

    Published in:
    Journal of Clinical Pharmacology, 2025, v. 65, n. 6, p. 751, doi. 10.1002/jcph.6187
    By:
    • Hayato, Seiichi;
    • Hamuro, Lora;
    • Shimizu, Toshio;
    • Yonemori, Kan;
    • Nishio, Shin;
    • Yunokawa, Mayu;
    • Yoshida, Tatsuya;
    • Nishio, Makoto;
    • Matsumoto, Koji;
    • Takehara, Kazuhiro;
    • Hasegawa, Kosei;
    • Kozuki, Toshiyuki;
    • Hirashima, Yasuyuki;
    • Kato, Hidenori;
    • Miura, Takuma;
    • Nomoto, Maiko;
    • Zhao, Yue;
    • Zhu, Li;
    • Yasuda, Sanae
    Publication type:
    Article
    10
    11
    12
    13
    14

    Gynecological Cancers Translational, Research Implementation, and Harmonization: Gynecologic Cancer InterGroup Consensus and Still Open Questions.

    Published in:
    Cells (2073-4409), 2019, v. 8, n. 3, p. 200, doi. 10.3390/cells8030200
    By:
    • Bagnoli, Marina;
    • Shi, Ting Yan;
    • Gourley, Charlie;
    • Speiser, Paul;
    • Reuss, Alexander;
    • Nijman, Hans W.;
    • Creutzberg, Carien L.;
    • Scholl, Suzy;
    • Negrouk, Anastassia;
    • Brady, Mark F.;
    • Hasegawa, Kosei;
    • Oda, Katsutoshi;
    • McNeish, Iain A.;
    • Kohn, Elise C.;
    • Oza, Amit M.;
    • MacKay, Helen;
    • Millan, David;
    • Bennett, Katherine;
    • Scott, Clare;
    • Mezzanzanica, Delia
    Publication type:
    Article
    15

    Correction: Integrated Copy Number and Expression Analysis Identifies Profiles of Whole-Arm Chromosomal Alterations and Subgroups with Favorable Outcome in Ovarian Clear Cell Carcinomas.

    Published in:
    PLoS ONE, 2015, v. 10, n. 7, p. 1, doi. 10.1371/journal.pone.0132751
    By:
    • Uehara, Yuriko;
    • Oda, Katsutoshi;
    • Ikeda, Yuji;
    • Koso, Takahiro;
    • Tsuji, Shingo;
    • Yamamoto, Shogo;
    • Asada, Kayo;
    • Sone, Kenbun;
    • Kurikawa, Reiko;
    • Makii, Chinami;
    • Hagiwara, Otoe;
    • Tanikawa, Michihiro;
    • Maeda, Daichi;
    • Hasegawa, Kosei;
    • Nakagawa, Shunsuke;
    • Wada-Hiraike, Osamu;
    • Kawana, Kei;
    • Fukayama, Masashi;
    • Fujiwara, Keiichi;
    • Yano, Tetsu
    Publication type:
    Article
    16

    Integrated Copy Number and Expression Analysis Identifies Profiles of Whole-Arm Chromosomal Alterations and Subgroups with Favorable Outcome in Ovarian Clear Cell Carcinomas.

    Published in:
    PLoS ONE, 2015, v. 10, n. 6, p. 1, doi. 10.1371/journal.pone.0128066
    By:
    • Uehara, Yuriko;
    • Oda, Katsutoshi;
    • Ikeda, Yuji;
    • Koso, Takahiro;
    • Tsuji, Shingo;
    • Yamamoto, Shogo;
    • Asada, Kayo;
    • Sone, Kenbun;
    • Kurikawa, Reiko;
    • Makii, Chinami;
    • Hagiwara, Otoe;
    • Tanikawa, Michihiro;
    • Maeda, Daichi;
    • Hasegawa, Kosei;
    • Nakagawa, Shunsuke;
    • Wada-Hiraike, Osamu;
    • Kawana, Kei;
    • Fukayama, Masashi;
    • Fujiwara, Keiichi;
    • Yano, Tetsu
    Publication type:
    Article
    17
    18
    19
    20
    21

    Phase II randomized study of dostarlimab alone or with bevacizumab versus non-platinum chemotherapy in recurrent gynecological clear cell carcinoma (DOVE/APGOT-OV7/ENGOT-OV80).

    Published in:
    Journal of Gynecologic Oncology, 2025, v. 36, n. 1, p. 1, doi. 10.3802/jgo.2025.36.e51
    By:
    • Jung-Yun Lee;
    • Tan, David;
    • Ray-Coquard, Isabelle;
    • Jung Bok Lee;
    • Byoung Gie Kim;
    • Van Nieuwenhuysen, Els;
    • Yun-Ju Huang, Ruby;
    • Ka Yu Tse;
    • González-Martin, Antonio;
    • Scott, Clare;
    • Hasegawa, Kosei;
    • Wilkinson, Katie;
    • Eun Yeong Yang;
    • Lheureux, Stephanie;
    • Kristeleit, Rebecca
    Publication type:
    Article
    22
    23

    Niraparib in Japanese patients with platinum-sensitive recurrent ovarian cancer: final results of a multicenter phase 2 study.

    Published in:
    Journal of Gynecologic Oncology, 2024, v. 35, n. 5, p. 1, doi. 10.3802/jgo.2024.35.e115
    By:
    • Hiroaki Itamochi;
    • Nobuhiro Takeshima;
    • Junzo Hamanishi;
    • Kosei Hasegawa;
    • Motoki Matsuura;
    • Kiyonori Miura;
    • Shoji Nagao;
    • Hidekatsu Nakai;
    • Naotake Tanaka;
    • Hideki Tokunaga;
    • Shin Nishio;
    • Hidemichi Watari;
    • Yoshihito Yokoyama;
    • Yoichi Kase;
    • Shuuji Sumino;
    • Ai Kato;
    • Ajit Suri;
    • Toshiaki Yasuoka;
    • Kazuhiro Takehara
    Publication type:
    Article
    24

    Niraparib in Japanese patients with heavily pretreated, homologous recombination-deficient ovarian cancer: final results of a multicenter phase 2 study.

    Published in:
    Journal of Gynecologic Oncology, 2024, v. 35, n. 5, p. 1, doi. 10.3802/jgo.2024.35.e114
    By:
    • Daisuke Aoki;
    • Tsutomu Tabata;
    • Satoshi Yanagida;
    • Toshiaki Nakamura;
    • Eiji Kondo;
    • Junzo Hamanishi;
    • Kenichi Harano;
    • Kosei Hasegawa;
    • Takeshi Hirasawa;
    • Kensuke Hori;
    • Shinichi Komiyama;
    • Motoki Matsuura;
    • Hidekatsu Nakai;
    • Hiroko Nakamura;
    • Jun Sakata;
    • Kazuhiro Takehara;
    • Munetaka Takekuma;
    • Yoshihito Yokoyama;
    • Yoichi Kase;
    • Shuuji Sumino
    Publication type:
    Article
    25

    Prevention of symptomatic pulmonary embolism for gynecologic malignancies with preoperative asymptomatic venous thromboembolism: GOTIC-VTE trial.

    Published in:
    Journal of Gynecologic Oncology, 2024, v. 35, n. 4, p. 1, doi. 10.3802/jgo.2024.35.e37
    By:
    • Yoshifumi Takahashi;
    • Hiroyuki Fujiwara;
    • Kouji Yamamoto;
    • Masashi Takano;
    • Morikazu Miyamoto;
    • Kosei Hasegawa;
    • Maiko Miwa;
    • Toyomi Satoh;
    • Hiroya Itagaki;
    • Takashi Hirakawa;
    • Mayuyo Mori-Uchino;
    • Tomonori Nagai;
    • Yoshinobu Hamada;
    • Soichi Yamashita;
    • Hiroko Yano;
    • Tomoyasu Kato;
    • Keiichi Fujiwara;
    • Mitsuaki Suzuki
    Publication type:
    Article
    26

    Analysis of East Asia subgroup in Study 309/KEYNOTE-775: lenvatinib plus pembrolizumab versus treatment of physician's choice chemotherapy in patients with previously treated advanced or recurrent endometrial cancer.

    Published in:
    Journal of Gynecologic Oncology, 2024, v. 35, n. 2, p. 1, doi. 10.3802/jgo.2024.35.e40
    By:
    • Kan Yonemori;
    • Keiichi Fujiwara;
    • Kosei Hasegawa;
    • Mayu Yunokawa;
    • Kimio Ushijima;
    • Shiro Suzuki;
    • Ayumi Shikama;
    • Shinichiro Minobe;
    • Tomoka Usami;
    • Jae-Weon Kim;
    • Byoung-Gie Kim;
    • Peng-Hui Wang;
    • Ting-Chang Chang;
    • Keiko Yamamoto;
    • Shirong Han;
    • McKenzie, Jodi;
    • Orlowski, Robert J.;
    • Takuma Miura;
    • Makker, Vicky;
    • Yong Man Kim
    Publication type:
    Article
    27

    Phase 2 single-arm study on the efficacy and safety of niraparib in Japanese patients with heavily pretreated, homologous recombination-deficient ovarian cancer.

    Published in:
    Journal of Gynecologic Oncology, 2021, v. 32, n. 2, p. 1, doi. 10.3802/jgo.2021.32.e16
    By:
    • Aikou Okamoto;
    • Eiji Kondo;
    • Toshiaki Nakamura;
    • Satoshi Yanagida;
    • Junzo Hamanishi;
    • Kenichi Harano;
    • Kosei Hasegawa;
    • Takeshi Hirasawa;
    • Kensuke Hori;
    • Shinichi Komiyama;
    • Motoki Matsuura;
    • Hidekatsu Nakai;
    • Hiroko Nakamura;
    • Jun Sakata;
    • Tsutomu Tabata;
    • Kazuhiro Takehara;
    • Munetaka Takekuma;
    • Yoshihito Yokoyama;
    • Yoichi Kase;
    • Shuuji Sumino
    Publication type:
    Article
    28

    Phase 2 single-arm study on the safety of maintenance niraparib in Japanese patients with platinum-sensitive relapsed ovarian cancer.

    Published in:
    Journal of Gynecologic Oncology, 2021, v. 32, n. 2, p. 1, doi. 10.3802/jgo.2021.32.e21
    By:
    • Kazuhiro Takehara;
    • Takashi Matsumoto;
    • Junzo Hamanishi;
    • Kosei Hasegawa;
    • Motoki Matsuura;
    • Kiyonori Miura;
    • Shoji Nagao;
    • Hidekatsu Nakai;
    • Naotake Tanaka;
    • Hideki Tokunaga;
    • Kimio Ushijima;
    • Hidemichi Watari;
    • Yoshihito Yokoyama;
    • Yoichi Kase;
    • Shuuji Sumino;
    • Suri, Ajit;
    • Hiroaki Itamochi;
    • Nobuhiro Takeshima
    Publication type:
    Article
    29
    30

    Clinical utility of CA-125 in the management of uterine carcinosarcoma.

    Published in:
    2018
    By:
    • Koji Matsuo;
    • Ross, Malcolm S.;
    • Mayu Yunokawa;
    • Johnson, Marian S.;
    • Hiroko Machida;
    • Kohei Omatsu;
    • Klobocista, Merieme M.;
    • Im, Dwight D.;
    • Shinya Satoh;
    • Tsukasa Baba;
    • Yuji Ikeda;
    • Bush, Stephen H.;
    • Kosei Hasegawa;
    • Blake, Erin A.;
    • Munetaka Takekuma;
    • Masako Shida;
    • Masato Nishimura;
    • Sosuke Adachi;
    • Tanja Pejovic;
    • Satoshi Takeuchi
    Publication type:
    Letter to the Editor
    31
    32

    Clinical outcomes and medical management of achondroplasia in Japanese children: A retrospective medical record review of clinical data.

    Published in:
    American Journal of Medical Genetics. Part A, 2024, v. 194, n. 8, p. 1, doi. 10.1002/ajmg.a.63612
    By:
    • Saitou, Hiroyuki;
    • Kitaoka, Taichi;
    • Kubota, Takuo;
    • Kanno, Junko;
    • Mochizuki, Hiroshi;
    • Michigami, Toshimi;
    • Hasegawa, Kosei;
    • Fujiwara, Ikuma;
    • Hamajima, Takashi;
    • Harada, Daisuke;
    • Seki, Yuko;
    • Nagasaki, Keisuke;
    • Dateki, Sumito;
    • Namba, Noriyuki;
    • Tokuoka, Hirofumi;
    • Pimenta, Jeanne M.;
    • Cohen, Shelda;
    • Ozono, Keiichi
    Publication type:
    Article
    33
    34
    35

    A novel mutation p.Ser348Cys in FGFR3 causes achondroplasia.

    Published in:
    American Journal of Medical Genetics. Part A, 2016, v. 170A, n. 5, p. 1370, doi. 10.1002/ajmg.a.37557
    By:
    • Hasegawa, Kosei;
    • Fukuhara, Rie;
    • Moriwake, Tadashi;
    • Tanaka, Hiroyuki;
    • Higuchi, Yousuke;
    • Yamashita, Miho;
    • Tsukahara, Hirokazu
    Publication type:
    Article
    36
    37
    38
    39
    40
    41
    42

    Pembrolizumab plus chemotherapy in Japanese patients with persistent, recurrent or metastatic cervical cancer: Results from KEYNOTE‐826.

    Published in:
    Cancer Science, 2022, v. 113, n. 11, p. 3877, doi. 10.1111/cas.15479
    By:
    • Nishio, Shin;
    • Yonemori, Kan;
    • Usami, Tomoka;
    • Minobe, Shinichiro;
    • Yunokawa, Mayu;
    • Iwata, Takashi;
    • Okamoto, Aikou;
    • Aoki, Yoichi;
    • Itamochi, Hiroaki;
    • Takekuma, Munetaka;
    • Harano, Kenichi;
    • Yamamoto, Keiko;
    • Maruko, Takeshi;
    • Ugai, Hiroyuki;
    • Tekin, Cumhur;
    • Colombo, Nicoletta;
    • Fujiwara, Keiichi;
    • Hasegawa, Kosei;
    • Ushijima, Kimio
    Publication type:
    Article
    43
    44
    45
    46
    47
    48
    49
    50